Search

Your search keyword '"Fogel, Brent L."' showing total 257 results

Search Constraints

Start Over You searched for: Author "Fogel, Brent L." Remove constraint Author: "Fogel, Brent L." Search Limiters Full Text Remove constraint Search Limiters: Full Text
257 results on '"Fogel, Brent L."'

Search Results

1. Lysosomal genes contribute to Parkinson’s disease near agriculture with high intensity pesticide use

2. Core protocol development for phase 2/3 clinical trials in the leukodystrophy vanishing white matter: a consensus statement by the VWM consortium and patient advocates

5. Toward a biomarker panel measured in CNS-originating extracellular vesicles for improved differential diagnosis of Parkinson’s disease and multiple system atrophy

6. De novo variants in DENND5B cause a neurodevelopmental disorder

7. Clinical application of a scale to assess genomic healthcare empowerment (GEmS): Process and illustrative case examples

8. Correction to: α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson’s disease from multiple system atrophy

9. α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson’s disease from multiple system atrophy

10. A syndromic neurodevelopmental disorder caused by rare variants in PPFIA3

11. miR-142-3p regulates cortical oligodendrocyte gene co-expression networks associated with tauopathy

12. Biallelic variants in ribonuclease inhibitor (RNH1), an inflammasome modulator, are associated with a distinctive subtype of acute, necrotizing encephalopathy

13. Lack of Association Between GBA Mutations and Motor Complications in European and American Parkinson’s Disease Cohorts

14. HNRNPC haploinsufficiency affects alternative splicing of intellectual disability-associated genes and causes a neurodevelopmental disorder

15. De novo missense variants in phosphatidylinositol kinase PIP5KIγ underlie a neurodevelopmental syndrome associated with altered phosphoinositide signaling

16. De novo variants in MRTFB have gain-of-function activity in Drosophila and are associated with a novel neurodevelopmental phenotype with dysmorphic features

17. Variants in SCAF4 Cause a Neurodevelopmental Disorder and Are Associated with Impaired mRNA Processing

18. Diagnostic utility of transcriptome sequencing for rare Mendelian diseases

19. A diagnostic ceiling for exome sequencing in cerebellar ataxia and related neurological disorders

20. Bi-allelic variants in INTS11 are associated with a complex neurological disorder

22. A concurrent dual analysis of genomic data augments diagnoses: Experiences of 2 clinical sites in the Undiagnosed Diseases Network

23. Cross-Sectional Analysis of Exome Sequencing Diagnosis in Patients With Neurologic Phenotypes Facing Barriers to Clinical Testing

24. De Novo Pathogenic Variants in N-cadherin Cause a Syndromic Neurodevelopmental Disorder with Corpus Collosum, Axon, Cardiac, Ocular, and Genital Defects

25. Heterozygous variants in MYBPC1 are associated with an expanded neuromuscular phenotype beyond arthrogryposis

26. IgG4‐related disease: Association with a rare gene variant expressed in cytotoxic T cells

27. Primary brain calcification: an international study reporting novel variants and associated phenotypes.

28. IRF2BPL Is Associated with Neurological Phenotypes

30. De novo variants in DENND5B cause a neurodevelopmental disorder

31. Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations

32. Heterozygous loss-of-function variants significantly expand the phenotypes associated with loss of GDF11

33. Prevalence of spinocerebellar ataxia 36 in a US population

34. A syndromic neurodevelopmental disorder caused by rare variants in PPFIA3

37. Mutations in XPR1 cause primary familial brain calcification associated with altered phosphate export.

38. Clinical Exome Sequencing for Genetic Identification of Rare Mendelian Disorders

39. Exome Sequencing in the Clinical Diagnosis of Sporadic or Familial Cerebellar Ataxia

40. Mutation of senataxin alters disease-specific transcriptional networks in patients with ataxia with oculomotor apraxia type 2

41. The Neurogenetics of Atypical Parkinsonian Disorders

43. Biallelic CRELD1 variants cause a multisystem syndrome including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections.

44. Biallelic variants in ribonuclease inhibitor (RNH1), an inflammasome modulator, are associated with a distinctive subtype of acute, necrotizing encephalopathy

45. Mutations in SLC20A2 are a major cause of familial idiopathic basal ganglia calcification

46. Candidate Screening of the TRPC3 Gene in Cerebellar Ataxia

47. Aberrant Splicing of the Senataxin Gene in a Patient with Ataxia with Oculomotor Apraxia Type 2

48. HNRNPC haploinsufficiency affects alternative splicing of intellectual disability-associated genes and causes a neurodevelopmental disorder

49. De novo missense variants in phosphatidylinositol kinase PIP5KIγ underlie a neurodevelopmental syndrome associated with altered phosphoinositide signaling

50. An intronic GAA repeat expansion in FGF14 causes the autosomal-dominant adult-onset ataxia SCA27B/ATX-FGF14

Catalog

Books, media, physical & digital resources